Landauer (NYSE: LDR) is one of 84 publicly-traded companies in the “Medical Equipment, Supplies & Distribution” industry, but how does it contrast to its peers? We will compare Landauer to similar businesses based on the strength of its dividends, risk, valuation, institutional ownership, profitability, analyst recommendations and earnings.

Institutional and Insider Ownership

79.5% of Landauer shares are held by institutional investors. Comparatively, 63.1% of shares of all “Medical Equipment, Supplies & Distribution” companies are held by institutional investors. 6.6% of Landauer shares are held by insiders. Comparatively, 13.0% of shares of all “Medical Equipment, Supplies & Distribution” companies are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Analyst Ratings

This is a breakdown of current ratings for Landauer and its peers, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Landauer 0 1 0 0 2.00
Landauer Competitors 162 1105 2434 88 2.65

As a group, “Medical Equipment, Supplies & Distribution” companies have a potential upside of 6.92%. Given Landauer’s peers stronger consensus rating and higher possible upside, analysts plainly believe Landauer has less favorable growth aspects than its peers.

Profitability

This table compares Landauer and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Landauer 12.09% 80.03% 10.11%
Landauer Competitors -127.12% -36.28% -10.20%

Earnings & Valuation

This table compares Landauer and its peers revenue, earnings per share and valuation.

Gross Revenue EBITDA Price/Earnings Ratio
Landauer $153.35 million $39.95 million 34.97
Landauer Competitors $827.23 million $159.49 million 36.30

Landauer’s peers have higher revenue and earnings than Landauer. Landauer is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Dividends

Landauer pays an annual dividend of $1.10 per share and has a dividend yield of 1.6%. Landauer pays out 57.0% of its earnings in the form of a dividend. As a group, “Medical Equipment, Supplies & Distribution” companies pay a dividend yield of 0.8% and pay out 37.3% of their earnings in the form of a dividend.

Risk & Volatility

Landauer has a beta of 1.29, suggesting that its stock price is 29% more volatile than the S&P 500. Comparatively, Landauer’s peers have a beta of 1.06, suggesting that their average stock price is 6% more volatile than the S&P 500.

Summary

Landauer peers beat Landauer on 9 of the 15 factors compared.

Landauer Company Profile

Landauer, Inc. is a provider of technical and analytical services to determine occupational and environmental radiation exposure. The Company is a provider of outsourced medical physics services, and a provider of radiology related medical products. The Company operates through three segments: Radiation Measurement, Medical Physics and Medical Products. The Company provides radiation dosimetry services to hospitals, medical and dental offices, universities, national laboratories, nuclear facilities and other industries. Medical physics services are provided through the Company’s Landauer Medical Physics (LMP) division. The Company uses LMP as a platform to expand into the medical physics services market, serving domestic hospitals, radiation therapy centers and imaging centers. The Company’s Medical Products segment provides medical consumable accessories used in radiology, radiation therapy and image guided surgery procedures.

Receive News & Ratings for Landauer Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Landauer Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.